000 | 01946 a2200553 4500 | ||
---|---|---|---|
005 | 20250515044522.0 | ||
264 | 0 | _c20061108 | |
008 | 200611s 0 0 eng d | ||
022 | _a1555-7162 | ||
024 | 7 |
_a10.1016/j.amjmed.2006.03.036 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBarberán, José | |
245 | 0 | 0 |
_aConservative treatment of staphylococcal prosthetic joint infections in elderly patients. _h[electronic resource] |
260 |
_bThe American journal of medicine _cNov 2006 |
||
300 |
_a993.e7-10 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aArthroplasty, Replacement, Hip _xadverse effects |
650 | 0 | 4 |
_aArthroplasty, Replacement, Knee _xadverse effects |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aDebridement |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHip Prosthesis _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJoint Prosthesis _xadverse effects |
650 | 0 | 4 |
_aKnee Prosthesis _xadverse effects |
650 | 0 | 4 | _aLevofloxacin |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMethicillin Resistance |
650 | 0 | 4 |
_aOfloxacin _xtherapeutic use |
650 | 0 | 4 |
_aProsthesis-Related Infections _xdrug therapy |
650 | 0 | 4 |
_aRifampin _xtherapeutic use |
650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
650 | 0 | 4 | _aStaphylococcus aureus |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAguilar, Lorenzo | |
700 | 1 | _aCarroquino, Guillermo | |
700 | 1 | _aGiménez, María-José | |
700 | 1 | _aSánchez, Beatriz | |
700 | 1 | _aMartínez, David | |
700 | 1 | _aPrieto, José | |
773 | 0 |
_tThe American journal of medicine _gvol. 119 _gno. 11 _gp. 993.e7-10 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjmed.2006.03.036 _zAvailable from publisher's website |
999 |
_c16645504 _d16645504 |